RECRUITING
NCT07883655
Advanced Multi-omics and -System Approaches to Identify Novel Biomarkers for SMA
Updated: Oct 20, 2026
- RECRUITINGNCT07805278
A Registry of Cases of Spinal Muscular Atrophy
Updated: Sep 30, 2026 - RECRUITINGNCT07554924
A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I
Updated: Oct 14, 2026 - RECRUITINGNCT07543003
An International Federated Model for Wearable-derived Remote Longitudinal Motor Monitoring in Young Children With Spinal Muscular Atrophy Compared With Healthy Controls: Active-NBS Study (UK)
Updated: May 11, 2026 - RECRUITINGNCT07531719
A Study of Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA)
Updated: Oct 2, 2026 - RECRUITINGNCT07521930
Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
Updated: Oct 9, 2026 - RECRUITINGNCT07488338
HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness
Updated: Mar 23, 2026 - RECRUITINGNCT07478172
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Updated: Mar 17, 2026 - RECRUITINGNCT07467187
Invasive Home Ventilation in Denmark
Updated: Apr 20, 2026 - RECRUITINGNCT07448610
ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
Updated: Sep 18, 2026 - RECRUITINGNCT07444476
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam
Updated: Oct 2, 2026 - RECRUITINGNCT07444450
A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
Updated: Oct 15, 2026 - RECRUITINGNCT07400198
Gait and Bone Health in SMA
Updated: Mar 18, 2026 - RECRUITINGNCT07332702
Long Read Analysis in Spinal Muscular Atrophy - LOREASI
Updated: Jan 12, 2026 - RECRUITINGNCT07321977
Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers
Updated: May 19, 2026 - RECRUITINGNCT07287982
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Updated: Oct 8, 2026 - RECRUITINGNCT07286565
Active NBS Study: Decentralised Monitoring Motor Development in Children With Duchenne Muscular Dystrophy or Spinal Muscular Atrophy Identified by Newborn Screening
Updated: Dec 16, 2025 - RECRUITINGNCT07231549
CuidAME: Longitudinal Data Collection From Patients With Spinal Muscular Atrophy in Spain
Updated: Nov 17, 2025 - RECRUITINGNCT07223489
Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System
Updated: Jan 16, 2026 - RECRUITINGNCT07221669
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Updated: Oct 21, 2026
Filter Search
Country*
Sex
Age Group
Observational & Interventional Studies
Expanded Access
Preferred Study Type
Evaluates effect of interventions, e.g. substances
e.g. Patient Registries
Save my filters & notify me of new trials!
Never miss a new SMA Clinical Trial
Register to receive email notifications of new trials matching your profile or updates to saved trials